Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS PharmaceuticalCSMYF 93 Interest Coverage is 106.01 as of Feb. 2026, which is 67% below its 10-year median of 319.98. GuruFocus rates CSMYF with a GF Score™ of 93/100 and a GF Value™ of $50.48 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 453 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks better than 83.89% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. COSMOS Pharmaceutical's
Operating Income
for the
three
months ended in Feb. 2026 was $73 Mil. COSMOS Pharmaceutical's Interest Expense for the
three
months ended in Feb. 2026 was $-1 Mil.
COSMOS Pharmaceutical's interest coverage for the quarter that ended in Feb. 2026 was 106.01.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for COSMOS Pharmaceutical's Interest Coverage or its related term are showing as below:
CSMYF'
s Interest Coverage Range Over the Past 10 Years
Min: 94.22 Med: 319.98 Max: 590.76
Current: 94.22
CSMYF's Interest Coverage is ranked better than 83.89% of 453
companies
in the Healthcare Providers & Services industry
Industry Median: 7.98
vs CSMYF: 94.22
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
COSMOS Pharmaceutical Interest Coverage Related Terms
COSMOS Pharmaceutical Interest Coverage Historical Data
* Premium members only.
The historical data trend for COSMOS Pharmaceutical's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical Interest Coverage vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Interest Coverage distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical (CSMYF) has a Interest Coverage of 106.01 as of Feb. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on COSMOS Pharmaceutical and its competitors. This is 67% below median its historical median of 319.98. Over the past decade, COSMOS Pharmaceutical's Interest Coverage has ranged from 94.22 to 590.76. According to the industry distribution chart, COSMOS Pharmaceutical ranks #73 out of 453 companies in the Healthcare Providers & Services industry, placing it in the top 16.1%.
Is COSMOS Pharmaceutical's Interest Coverage too high?
COSMOS Pharmaceutical's current Interest Coverage of 106.01 is 67% below median its 10-year median of 319.98. Over the past 10 years, this metric has ranged from a low of 94.22 to a high of 590.76. The Healthcare Providers & Services industry median Interest Coverage is 7.98. COSMOS Pharmaceutical's value of 106.01 is 1228.4% above this industry median. Based on the distribution chart, COSMOS Pharmaceutical ranks #73 out of 453 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, COSMOS Pharmaceutical has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Interest Coverage compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #73 out of 453 companies for Interest Coverage. This places COSMOS Pharmaceutical in the top 16% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 7.98. COSMOS Pharmaceutical's value of 106.01 is 1228.4% above this benchmark. Historically, COSMOS Pharmaceutical's own Interest Coverage has ranged from 94.22 to 590.76 over the past decade. While the company's 10-year median is 319.98 vs. the industry median of 7.98, COSMOS Pharmaceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Providers & Services company?
The median Interest Coverage among Healthcare Providers & Services companies is 7.98, based on 453 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. COSMOS Pharmaceutical's current Interest Coverage of 106.01 is 1228.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on COSMOS Pharmaceutical and its competitors. For the Healthcare Providers & Services industry, the median Interest Coverage is 7.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current Interest Coverage is 106.01, which is 67% below median its own 10-year median of 319.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (CSMYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $50.48, compared to a current price of $37.06 — trading 26.6% below its estimated fair value. The current Interest Coverage is 106.01, which is 67% below median its 10-year median of 319.98 and 1228.4% above the Healthcare Providers & Services industry median of 7.98. COSMOS Pharmaceutical's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Interest Coverage is 106.01 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 26.6% below its estimated GF Value™ of $50.48.
GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.
Key valuation signals for CSMYF:
Interest Coverage: 106.01 (67% below median its 10-year median of 319.98)
GF Value™: $50.48 vs. price of $37.06 (26.6% below fair value)
Industry Position: 1228.4% above the Healthcare Providers & Services median (#73 of 453)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score
Get the complete analysis for CSMYF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
